NCT06710574 - Multimodal Image Technologies Investigate the Role and Mechanism of Probiotics in Improving RBD with Parkinson's Disease | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

June 1, 2025

Study Completion Date

June 30, 2025

Conditions

Parkinson DiseaseMovement DisordersRapid Eye Movement Sleep Behavior DisorderGut MicrobiomesMagnetic Resonance Imaging (MRI)Probiotic

Interventions

DRUG

PD-RBD

Bifidobacterium triple viable capsule (Bifico Capsule, Shanghai Shangyao Xinyi Pharmaceutical Factory Co., LTD.) 420mg, two times a day, 4 capsules each time; At the same time give the bacillus licheniformis living bacterium capsule (whole bowel capsule, northeast pharmaceutical) 0.5 g, three times a day, two at a time, keep the original anti Parkinson's drugs

DRUG

iRBD

Bifidobacterium triple viable capsule (Bifico Capsule, Shanghai Shangyao Xinyi Pharmaceutical Factory Co., LTD.) 420mg, two times a day, 4 capsules each time; At the same time give the bacillus licheniformis living bacterium capsule (whole bowel capsule, northeast pharmaceutical) 0.5 g, three times a day, two at a time.

Trial Locations (1)

100050

RECRUITING

Beijing Friendship Hospital, Capital Medical University, Beijing